NCT02932280 Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02910752 CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation Status SUSPENDED Phase PHASE1/PHASE2
NCT02910583 Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL) Status COMPLETED Phase PHASE2
NCT02872987 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial Status RECRUITING Phase N/A
NCT02859389 Neurocognitive and Psychosocial Outcomes in Survivors of Childhood Leukemia With Down Syndrome Status COMPLETED Phase N/A
NCT02829840 Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML) Status WITHDRAWN Phase PHASE1/PHASE2
NCT02796365 Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy Status COMPLETED Phase NA
NCT02795182 Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies Status COMPLETED Phase PHASE1
NCT02786485 Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT Status WITHDRAWN Phase PHASE1
NCT02784561 Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation Status UNKNOWN Phase PHASE4
NCT02773732 Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101) Status TERMINATED Phase PHASE1/PHASE2
NCT02763475 NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents Status COMPLETED Phase PHASE2
NCT02755480 Ultralow Dose Thoracic Computed Tomography in Immunocompromised Patients Status TERMINATED Phase NA
NCT02748850 Evaluation of the Effectiveness of an Aldehyde Inhibitor Dehydrogenases (DIMATE) on the Cell Population Leukemic or Normal Stem Status UNKNOWN Phase NA
NCT02735291 Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemia Status ACTIVE_NOT_RECRUITING Phase NA
NCT02730884 Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia Status TERMINATED Phase PHASE2
NCT02723994 A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2